Showing results (1491-1500 of 1,545) with videos related to
Sort By:
Pageof 155
Digestive Diseases and Sciences|December 21, 2024
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic ReviewElina En Li Cho, Michelle Law, Zhenning Yu, et al.The American Journal of Surgical Pathology|May 17, 2019
Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord DifferentiationCheng-Han Lee, Yu-Chien Kao, Wan-Ru Lee, et al.Alimentary Pharmacology & Therapeutics|July 6, 2022
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectivesCheng Han Ng, Wen Hui Lim, Yip Han Chin, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|November 20, 2012
[Distribution of chromium in whole blood and urine among general population in China between year 2009 and 2010]Chun-guang Ding, Ya-juan Pan, Ai-hua Zhang, et al.Frontiers in Cardiovascular Medicine|August 25, 2022
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortalityCheng Han Ng, Zhen Yu Wong, Nicholas W S Chew, et al.Transplantation|June 16, 2026
Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree AnalysisNicole Shu Ying Tang, Margaret L P Teng, Asvin Selvakumar, et al.Cancer Research|August 30, 2014
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signalingShan Gao, Ilirjana Bajrami, Clare Verrill, et al.The Lancet. Gastroenterology & Hepatology|November 18, 2022
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysisJingxuan Quek, Kai En Chan, Zhen Yu Wong, et al.International Journal of Obesity (2005)|May 30, 2023
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysisBryan Tan, Xin-Hui Pan, Han Shi Jocelyn Chew, et al.Cancer Research|July 18, 2018
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast CancerTe-Chia Wu, Kangling Xu, Jan Martinek, et al.Pageof 155